Phase II trial of the combination of bevacizumab and erlotinib in patients who have advanced hepatocellular carcinoma. (Q33382749)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Phase II trial of the combination of bevacizumab and erlotinib in patients who have advanced hepatocellular carcinoma. |
scientific article |
Statements
Phase II trial of the combination of bevacizumab and erlotinib in patients who have advanced hepatocellular carcinoma (English)
Melanie B Thomas
Jeffrey S Morris
Michiko Iwasaki
E Lin
Ahmed Kaseb
Katrina Glover
Marta Davila
James Abbruzzese